113 related articles for article (PubMed ID: 21630390)
1. Stereo-specific inhibition of acetyl- and butyryl-cholinesterases by enantiomers of cis,cis-decahydro-2-naphthyl-N-n-butylcarbamate.
Lin MC; Yeh SJ; Chen IR; Lin G
J Biochem Mol Toxicol; 2011; 25(5):330-9. PubMed ID: 21630390
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Pseudomonas lipase inhibition study of stereoisomers of decahydro-2-naphthyl-N-n-butylcarbamate.
Lin MC; Shen YF; Lin G
Protein Pept Lett; 2011 Nov; 18(11):1168-76. PubMed ID: 21675951
[TBL] [Abstract][Full Text] [Related]
3. Substrate activation of butyrylcholinesterase and substrate inhibition of acetylcholinesterase by 3,3-dimethylbutyl-N-n-butylcarbamate and 2-trimethylsilyl-ethyl-N-n-butylcarbamate.
Chiou SY; Wu YG; Lin YF; Lin LY; Lin G
J Biochem Mol Toxicol; 2007; 21(1):24-31. PubMed ID: 17366539
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of enantiomers of exo-2-norbornyl-N-n-butylcarbamate and endo-2-norbornyl-N-n-butylcarbamate for stereoselective inhibition of acetylcholinesterase.
Chiou SY; Huang CF; Yeh SJ; Chen IR; Lin G
Chirality; 2010 Feb; 22(2):267-74. PubMed ID: 19496158
[TBL] [Abstract][Full Text] [Related]
5. Novel alkyl- and arylcarbamate derivatives with N-benzylpiperidine and N-benzylpiperazine moieties as cholinesterases inhibitors.
Więckowska A; Bajda M; Guzior N; Malawska B
Eur J Med Chem; 2010 Dec; 45(12):5602-11. PubMed ID: 20926161
[TBL] [Abstract][Full Text] [Related]
6. Ortho effects for inhibition mechanisms of butyrylcholinesterase by o-substituted phenyl N-butyl carbamates and comparison with acetylcholinesterase, cholesterol esterase, and lipase.
Lin G; Lee YR; Liu YC; Wu YG
Chem Res Toxicol; 2005 Jul; 18(7):1124-31. PubMed ID: 16022504
[TBL] [Abstract][Full Text] [Related]
7. Enantiomeric inhibitors of cholesterol esterase and acetylcholinesterase.
Lin G; Tsai YC; Liu HC; Liao WC; Chang CH
Biochim Biophys Acta; 1998 Oct; 1388(1):161-74. PubMed ID: 9774723
[TBL] [Abstract][Full Text] [Related]
8. Comparison of active sites of butyrylcholinesterase and acetylcholinesterase based on inhibition by geometric isomers of benzene-di-N-substituted carbamates.
Chiou SY; Huang CF; Hwang MT; Lin G
J Biochem Mol Toxicol; 2009; 23(5):303-8. PubMed ID: 19827033
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective inhibition of butyrylcholinesterase by enantiomers of exo- and endo-2-norbornyl-N-n-butylcarbamates.
Chiou SY; Huang CF; Yeh SJ; Chen IR; Lin G
J Enzyme Inhib Med Chem; 2010 Feb; 25(1):13-20. PubMed ID: 20030505
[TBL] [Abstract][Full Text] [Related]
10. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
[TBL] [Abstract][Full Text] [Related]
11. [Lipase-catalyzed resolution of 2-dialkylaminomethylcyclanols. Comparative studies].
Forró E; Fülöp F
Acta Pharm Hung; 1999 Jun; 69(3):155-8. PubMed ID: 10401159
[TBL] [Abstract][Full Text] [Related]
12. Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase.
Darvesh S; Darvesh KV; McDonald RS; Mataija D; Walsh R; Mothana S; Lockridge O; Martin E
J Med Chem; 2008 Jul; 51(14):4200-12. PubMed ID: 18570368
[TBL] [Abstract][Full Text] [Related]
13. Activation mechanisms of butyrylcholinesterase by 2,4,6-trinitrotoluene, 3,3-dimethylbutyl-N-n-butylcarbamate, and 2-trimethylsilyl-ethyl-N-n-butylcarbamate.
Chiou SY; Wu YG; Lin G
Appl Biochem Biotechnol; 2008 Sep; 150(3):337-44. PubMed ID: 18563305
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors.
Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Kunimoto R; Tsumura Y; Akaike A; Niidome T; Okuno Y; Takahashi T; Sugimoto H
Bioorg Med Chem Lett; 2010 Mar; 20(5):1718-20. PubMed ID: 20137934
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of carbamate-modified (-)-N(1)-phenethylnorphysostigmine derivatives as selective butyrylcholinesterase inhibitors.
Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Tsumura Y; Akaike A; Niidome T; Takahashi T; Sugimoto H
Bioorg Med Chem Lett; 2010 Mar; 20(5):1721-3. PubMed ID: 20137941
[TBL] [Abstract][Full Text] [Related]
16. A rate determining step change in the pre-steady state of acetylcholinesterase inhibitions by 1,n-alkane-di-N-butylcarbamates.
Lin G; Tseng HC; Chio AC; Tseng TM; Tsai BY
Bioorg Med Chem Lett; 2005 Feb; 15(4):951-5. PubMed ID: 15686892
[TBL] [Abstract][Full Text] [Related]
17. Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors.
Carolan CG; Dillon GP; Gaynor JM; Reidy S; Ryder SA; Khan D; Marquez JF; Gilmer JF
J Med Chem; 2008 Oct; 51(20):6400-9. PubMed ID: 18817366
[TBL] [Abstract][Full Text] [Related]
18. Benzene-1,2-, 1,3-, and 1,4-di-N-substituted carbamates as conformationally constrained inhibitors of acetylcholinesterase.
Lin MC; Hwang MT; Chang HG; Lin CS; Lin G
J Biochem Mol Toxicol; 2007; 21(6):348-53. PubMed ID: 17994573
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel phosphorothioates and phosphorodithioates and their differential inhibition of cholinesterases.
Kaboudin B; Emadi S; Hadizadeh A
Bioorg Chem; 2009 Aug; 37(4):101-5. PubMed ID: 19481235
[TBL] [Abstract][Full Text] [Related]
20. Specificity and orientation of trigonal carboxyl esters and tetrahedral alkylphosphonyl esters in cholinesterases.
Hosea NA; Berman HA; Taylor P
Biochemistry; 1995 Sep; 34(36):11528-36. PubMed ID: 7547883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
